The Mount Sinai Medical Center and ENT and Allergy Associates LLP Team Up to Fight Esophageal Cancer
Academic and Community Medicine join to battle the fastest growing cancer in America which frequently presents with chronic cough
The Mount Sinai Medical Center and ENT and Allergy Associates® (ENTA) today announced that they are expanding their first-of-its-kind clinical affiliation to screen and treat patients for esophageal cancer. The type of esophageal cancer that is related to acid reflux disease and adenocarcinoma of the esophagus, has seen a 500 percent increase in incidence in men and a 300 percent increase in incidence in women since 1975, according to the National Cancer Institute.
The partnership between Mount Sinai and ENTA has helped nearly 2,000 patients since 2007 as a result of a comprehensive screening and treatment program for head and neck cancer. Once again, Mount Sinai and ENTA will provide an expedited path to comprehensive state-of-the-art healthcare, allowing patients to benefit from a seamless diagnostic and treatment program that begins with an examination in the comfort of their local ENT and Allergy Associates office. If further care is needed, the patient is then transitioned to a GI doctor in their community, and/or in the case of a suspected lesion, to the Division of Gastroenterology at The Mount Sinai Medical Center.
“Esophageal cancer often presents itself as a chronic cough before actual swallowing problems show up,” said Dr. Jonathan Aviv, Clinical Director of the Voice and Swallowing Center™ at ENT and Allergy Associates. “Raising awareness as early as possible among our patients allows us to screen them—using minimally invasive techniques pioneered by doctors at ENT and Allergy Associates—and then send them to Mount Sinai for treatment that may possibly save their lives. Aviv continued “And unlike colon cancer screening, which requires a bowel prep and intravenous sedation with loss of a day from work, screening of the esophagus takes mere minutes to perform, does not require a prep and is carried out with the patient completely awake without intravenous medication or loss of a day of work. The technique is called TransNasal Esophagoscopy (TNE).”
Added Dr. Sharmila Anandasabapathy, Director of Endoscopy in Mount Sinai’s Division of Gastroenterology in the Department of Medicine at The Mount Sinai Medical Center, “We are delighted to be closely aligned with our colleagues at ENTA in encouraging patients to seek early detection, screening, and intervention. If esophageal cancer is diagnosed in its earliest stages, the patient’s chances of living and being cancer free after treatment are greatly improved.”
Commented Dr. Wayne Eisman, President of ENTA, “Expanding our clinical affiliation with Mount Sinai to now include the diagnosis and treatment of esophageal cancer, as well as head and neck cancer, ensures that our patients are receiving the very finest medical care possible. I am extremely proud that we are part of such an innovative and valuable affiliation.”
To learn more about your risk, visit www.entandallergy.com/ec.php.
About ENT and Allergy Associates
ENT and Allergy Associates, LLP is the largest and most comprehensive ear, nose, throat, allergy and audiology practice in the nation with 35 offices and over 115 physicians. Each location provides a full complement of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, and hearing aid dispensing. Visit www.entandallergy.com for more information. The practice has a clinical alliance with the Mount Sinai Medical Center for the treatment of diseases of the head and neck and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and cancer. The Practice has also recently expanded its clinical capabilities to include advanced Immunodeficiency trials.
To learn more about the benefits of ENT and Allergy Associates, please visit www.entandallergy.com.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of few medical schools embedded in a hospital in the United States. It has more than 3,400 faculty in 32 departments and 15 institutes, and ranks among the top 20 medical schools both in National Institute of Health funding and by U.S. News & World Report. The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. U.S. News & World Report consistently ranks The Mount Sinai Hospital among the nation's best hospitals based on reputation, patient safety, and other patient-care factors. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.